March 24, 2018 3:50 PM ET


Company Overview of SomantiX B.V.

Company Overview

SomantiX B.V., a biotech company, focuses on the development of angiogenesis inhibitors for the treatment of solid cancers through targeting of tumor blood vessels. The company was founded in 2008 and is based in Bilthoven, the Netherlands.

Professor Bronkhorstlaan 10-92

Bilthoven,  3723 MB


Founded in 2008


31 30 229 6092

Key Executives for SomantiX B.V.

Managing Director
Chief Scientific Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
ACS Biomarker B.V. Europe
Agventure Exploitatie BV Europe
Alloksys Life Sciences BV Europe
AM-Pharma B.V. Europe
Amarna Therapeutics B.V. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SomantiX B.V., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at